Literature DB >> 1991326

Quantitative clonal analysis of the B cell repertoire in human lupus.

M Zouali1, G J Fournié, J Thèze.   

Abstract

To gain further insight into the origin of autoantibody hyperproduction in human lupus, we quantitated the B cell repertoire toward exogenous and self-antigens. Using the Spot-ELISA method and two panels of nine exogenous and 10 self-antigens, we found that the normal human immune repertoire comprises a high frequency of B cell precursors secreting IgM antibodies to self- and exogenous determinants. This repertoire was markedly deficient in precursors producing IgG able to bind self-antigens. In lupus patients, the absolute numbers of clone precursors of the immune repertoire expressing IgM receptors whose paratopes impart affinity to self- and exogenous determinants were higher than in control individuals. Additionally, IgG antibody-forming cell precursors with binding specificity for lupus-associated antigens were detectable in the repertoire of these patients. Based on these results, we propose that hyperproduction of human lupus-associated autoantibodies arises in a two-stage mechanism whereby a general activation of the multireactive immune B cell repertoire precedes an oligospecific expansion of selected B cell clonotypes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991326     DOI: 10.1016/0008-8749(91)90188-h

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Glomerular immune deposits in murine lupus models may contain histones.

Authors:  T Schmiedeke; F Stoeckl; S Muller; Y Sugisaki; S Batsford; R Woitas; A Vogt
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 2.  Human autoantibodies and their genes.

Authors:  M Zouali
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

3.  Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE).

Authors:  J Schwab; A Lukowsky; H D Volk; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.